406 related articles for article (PubMed ID: 16101740)
1. Effect of combined treatment with methylprednisolone and soluble Nogo-66 receptor after rat spinal cord injury.
Ji B; Li M; Budel S; Pepinsky RB; Walus L; Engber TM; Strittmatter SM; Relton JK
Eur J Neurosci; 2005 Aug; 22(3):587-94. PubMed ID: 16101740
[TBL] [Abstract][Full Text] [Related]
2. Immunization with recombinant Nogo-66 receptor (NgR) promotes axonal regeneration and recovery of function after spinal cord injury in rats.
Yu P; Huang L; Zou J; Yu Z; Wang Y; Wang X; Xu L; Liu X; Xu XM; Lu PH
Neurobiol Dis; 2008 Dec; 32(3):535-42. PubMed ID: 18930141
[TBL] [Abstract][Full Text] [Related]
3. Nogo-66 receptor prevents raphespinal and rubrospinal axon regeneration and limits functional recovery from spinal cord injury.
Kim JE; Liu BP; Park JH; Strittmatter SM
Neuron; 2004 Oct; 44(3):439-51. PubMed ID: 15504325
[TBL] [Abstract][Full Text] [Related]
4. Resistance of interleukin-6 to the extracellular inhibitory environment promotes axonal regeneration and functional recovery following spinal cord injury.
Yang G; Tang WY
Int J Mol Med; 2017 Feb; 39(2):437-445. PubMed ID: 28075461
[TBL] [Abstract][Full Text] [Related]
5. Blockade of Nogo-66, myelin-associated glycoprotein, and oligodendrocyte myelin glycoprotein by soluble Nogo-66 receptor promotes axonal sprouting and recovery after spinal injury.
Li S; Liu BP; Budel S; Li M; Ji B; Walus L; Li W; Jirik A; Rabacchi S; Choi E; Worley D; Sah DW; Pepinsky B; Lee D; Relton J; Strittmatter SM
J Neurosci; 2004 Nov; 24(46):10511-20. PubMed ID: 15548666
[TBL] [Abstract][Full Text] [Related]
6. Delayed systemic Nogo-66 receptor antagonist promotes recovery from spinal cord injury.
Li S; Strittmatter SM
J Neurosci; 2003 May; 23(10):4219-27. PubMed ID: 12764110
[TBL] [Abstract][Full Text] [Related]
7. Nogo-66 receptor antagonist peptide (NEP1-40) administration promotes functional recovery and axonal growth after lateral funiculus injury in the adult rat.
Cao Y; Shumsky JS; Sabol MA; Kushner RA; Strittmatter S; Hamers FP; Lee DH; Rabacchi SA; Murray M
Neurorehabil Neural Repair; 2008; 22(3):262-78. PubMed ID: 18056009
[TBL] [Abstract][Full Text] [Related]
8. The effect of growth factors and soluble Nogo-66 receptor protein on transplanted neural stem/progenitor survival and axonal regeneration after complete transection of rat spinal cord.
Guo X; Zahir T; Mothe A; Shoichet MS; Morshead CM; Katayama Y; Tator CH
Cell Transplant; 2012; 21(6):1177-97. PubMed ID: 22236767
[TBL] [Abstract][Full Text] [Related]
9. Delayed Nogo receptor therapy improves recovery from spinal cord contusion.
Wang X; Baughman KW; Basso DM; Strittmatter SM
Ann Neurol; 2006 Nov; 60(5):540-549. PubMed ID: 16958113
[TBL] [Abstract][Full Text] [Related]
10. Transgenic inhibition of Nogo-66 receptor function allows axonal sprouting and improved locomotion after spinal injury.
Li S; Kim JE; Budel S; Hampton TG; Strittmatter SM
Mol Cell Neurosci; 2005 May; 29(1):26-39. PubMed ID: 15866044
[TBL] [Abstract][Full Text] [Related]
11. Nogo-66 receptor antagonist peptide promotes axonal regeneration.
GrandPré T; Li S; Strittmatter SM
Nature; 2002 May; 417(6888):547-51. PubMed ID: 12037567
[TBL] [Abstract][Full Text] [Related]
12. A re-assessment of the effects of a Nogo-66 receptor antagonist on regenerative growth of axons and locomotor recovery after spinal cord injury in mice.
Steward O; Sharp K; Yee KM; Hofstadter M
Exp Neurol; 2008 Feb; 209(2):446-68. PubMed ID: 18234196
[TBL] [Abstract][Full Text] [Related]
13. Soluble cell adhesion molecule L1-Fc promotes locomotor recovery in rats after spinal cord injury.
Roonprapunt C; Huang W; Grill R; Friedlander D; Grumet M; Chen S; Schachner M; Young W
J Neurotrauma; 2003 Sep; 20(9):871-82. PubMed ID: 14577865
[TBL] [Abstract][Full Text] [Related]
14. Combined NgR vaccination and neural stem cell transplantation promote functional recovery after spinal cord injury in adult rats.
Xu CJ; Xu L; Huang LD; Li Y; Yu PP; Hang Q; Xu XM; Lu PH
Neuropathol Appl Neurobiol; 2011 Feb; 37(2):135-55. PubMed ID: 20819171
[TBL] [Abstract][Full Text] [Related]
15. Ensheathing cells and methylprednisolone promote axonal regeneration and functional recovery in the lesioned adult rat spinal cord.
Nash HH; Borke RC; Anders JJ
J Neurosci; 2002 Aug; 22(16):7111-20. PubMed ID: 12177207
[TBL] [Abstract][Full Text] [Related]
16. Effect of combined treatment with methylprednisolone and Nogo-A monoclonal antibody after rat spinal cord injury.
Wu J; Yang H; Qiu Z; Zhang Q; Ding T; Geng D
J Int Med Res; 2010; 38(2):570-82. PubMed ID: 20515570
[TBL] [Abstract][Full Text] [Related]
17. Anti-Nogo-A antibody treatment enhances sprouting of corticospinal axons rostral to a unilateral cervical spinal cord lesion in adult macaque monkey.
Freund P; Wannier T; Schmidlin E; Bloch J; Mir A; Schwab ME; Rouiller EM
J Comp Neurol; 2007 Jun; 502(4):644-59. PubMed ID: 17394135
[TBL] [Abstract][Full Text] [Related]
18. The use of a gold nanoparticle-based adjuvant to improve the therapeutic efficacy of hNgR-Fc protein immunization in spinal cord-injured rats.
Wang YT; Lu XM; Zhu F; Huang P; Yu Y; Zeng L; Long ZY; Wu YM
Biomaterials; 2011 Nov; 32(31):7988-98. PubMed ID: 21784510
[TBL] [Abstract][Full Text] [Related]
19. Dose-dependent beneficial and detrimental effects of ROCK inhibitor Y27632 on axonal sprouting and functional recovery after rat spinal cord injury.
Chan CC; Khodarahmi K; Liu J; Sutherland D; Oschipok LW; Steeves JD; Tetzlaff W
Exp Neurol; 2005 Dec; 196(2):352-64. PubMed ID: 16154567
[TBL] [Abstract][Full Text] [Related]
20. Nogo receptor decoy promotes recovery and corticospinal growth in non-human primate spinal cord injury.
Wang X; Zhou T; Maynard GD; Terse PS; Cafferty WB; Kocsis JD; Strittmatter SM
Brain; 2020 Jun; 143(6):1697-1713. PubMed ID: 32375169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
